On the history of biological drugs: the true discovery of the IL-1 receptor antagonist
Published: July 19 2012
Abstract Views: 757
PDF (Italian): 393
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Altmetrics
Downloads
Download data is not yet available.
Citations
How to Cite
On the history of biological drugs: the true discovery of the IL-1 receptor antagonist. (2012). Reumatismo, 64(3), 180. https://doi.org/10.4081/reumatismo.2012.180
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- G. Pasero, P. Marson, B. Gatto, A short history of anti-rheumatic therapy - VII. Biological agents , Reumatismo: Vol. 63 No. 3 (2011)
- L. Punzi, A. Pérez Negrete, P. Marson, M.A. Cimmino, M. Po', R. Gerli, L. Sinigaglia, The Institute for the History of Rheumatology, an offspring of the Italian Society of Rheumatology, is born in Venice , Reumatismo: Vol. 73 No. 1 (2021)
- G. Pasero, P. Marson, Short story of antirheumatic therapy.VIII. The immunodepressants , Reumatismo: Vol. 64 No. 1 (2012)
- M. Ferraris, Remembering Stefano Di Vittorio , Reumatismo: Vol. 63 No. 3 (2011)
- F. Oliviero, Il XLIV Congresso della Società Italiana di Reumatologia , Reumatismo: Vol. 59 No. 4 (2007)
- G. Pasero, P. Marson, Outlining the historical stages of anti-rheumatic therapy: a reflection for the today’s rheumatologist , Reumatismo: Vol. 62 No. 1 (2010)
- S. Parisi, M. Bruzzone, C. Centanaro Di Vittorio, A. Laganà, C.L. Peroni, E. Fusaro, Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids , Reumatismo: Vol. 65 No. 6 (2013)
- F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro, Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs , Reumatismo: Vol. 66 No. 3 (2014)
- S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri, Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center , Reumatismo: Vol. 64 No. 3 (2012)
- M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR, Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature , Reumatismo: Vol. 65 No. 4 (2013)
1-10 of 147
Next
You may also start an advanced similarity search for this article.
